New: Sponsored, no-charge genetic testing and counseling for individuals diagnosed with pancreatic cancer. Learn more.
New: Reata and Invitae are offering a sponsored, no-charge genetic testing program for chronic kidney disease. Learn more.
SMA Identified: Now more testing options to help confirm a clinical diagnosis or assess the carrier status of SMA. Learn more.
Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria for specific disorders. Invitae’s approach combines industry-leading genetics with an extensive network of patients and clinicians.
Invitae’s mission aligns with the missions of many advocacy groups. We are committed to ensuring that patients get the genetic answers they need.
Invitae works with academic and commercial partners, driving forward research and genomic health programs that strive to improve healthcare through high-quality, affordable genetic testing.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.